Valence Life Sciences: Proprietary Investment Strategy

Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.

Experienced team has insight on what drives success from assessing management and clinical development plans for over 25 years

Disciplined and successful approach that has established Valence Advantage's reputation as a preferred investor for late-stage private and micro-cap public companies

Insight on what drives success is key to assessing management and their clinical plan